Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Pre-Clinical
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014 12:36:29 PM
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014 11:21:05 AM
Kolltan Pharmaceuticals Inc. Presents KTN3379 Clinical And Preclinical Data At International Cancer Meeting 11/20/2014 11:11:07 AM
Nektar Therapeutics (CA) (NKTR) Presents Preclinical Study Findings For Etirinotecan Pegol (NKTR-102) In Combination With A PARP Inhibitor In BRCA1-Deficient Cancer Model 11/20/2014 10:09:11 AM
Inovio Pharmaceuticals (INO) Melanoma DNA Immunotherapy Inhibits Tumor Growth And Increases Survival In Preclinical Study 11/20/2014 10:07:59 AM
Kadmon Corporation Presents Preclinical Data On Bi-Functional Anti-PD-L1/IL-15 Fusion Protein At EORTC-NCI-AACR Symposium 11/19/2014 1:00:57 PM
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014 9:36:30 AM
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On RNAi Therapeutic Programs For Cardio-Metabolic Diseases At American Heart Association Scientific Sessions 2014 11/18/2014 12:42:30 PM
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014 1:15:28 PM
Enzyme Bio-Systems Ltd. Announces An Independent Research Group Reported Breast Cancer Preventive Efficacy For A Novel Synthetic Triterpenoid 11/17/2014 12:16:28 PM
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014 11:28:11 AM
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014 10:21:23 AM
AstraZeneca PLC (AZN) To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta 11/13/2014 6:08:19 AM
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014 11:29:31 AM
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014 6:09:31 AM
1234567
//-->